PHARMACEUTICAL COMPOSITION FOR TREATING ACUTE MYELOID LEUKEMIA WITH FLT3 MUTATION

摘要

To provide a novel, safe and effective pharmaceutical composition for treating acute myeloid leukemia with FLT3 mutation.SOLUTION: The invention provides a pharmaceutical composition to be administered to a subject having acute myeloid leukemia (AML) with FMS-like tyrosine kinase 3 (FLT3) mutation, where the composition comprises as an active ingredient a CXCR4-antagonistic peptide of a specific sequence, where cytarabine is administered to the subject.SELECTED DRAWING: None